•
Shares of FMC Corporation (FMC) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (DD) crop protection business.
• BlackBerry Ltd’s (BBRY) shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share
• Shares of Akari Therapeutics, Plc (AKTX) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)
• TRC Companies, Inc.’s (TRR) shares gained 46% after private equity firm New Mountain Capital decided to acquire the company
• Shares of FMC Corporation (FMC) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (DD) crop protection business.
• BlackBerry Ltd’s (BBRY) shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share
• Shares of Akari Therapeutics, Plc (AKTX) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)
• TRC Companies, Inc.’s (TRR) shares gained 46% after private equity firm New Mountain Capital decided to acquire the company
• Shares of FMC Corporation (FMC) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (DD) crop protection business.
• BlackBerry Ltd’s (BBRY) shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share
• Shares of Akari Therapeutics, Plc (AKTX) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)
• TRC Companies, Inc.’s (TRR) shares gained 46% after private equity firm New Mountain Capital decided to acquire the company
• Shares of FMC Corporation (FMC) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (DD) crop protection business.
• BlackBerry Ltd’s (BBRY) shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share
• Shares of Akari Therapeutics, Plc (AKTX) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)
• TRC Companies, Inc.’s (TRR) shares gained 46% after private equity firm New Mountain Capital decided to acquire the company
- Shares of FMC Corporation (NYSE:FMC) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (NYSE:DD) crop protection business.
- BlackBerry Ltd’s (NASDAQ:BBRY) shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share
- Shares of Akari Therapeutics, Plc (NASDAQ:AKTX) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)
- TRC Companies, Inc.’s (NYSE:TRR) shares gained 46% after private equity firm New Mountain Capital decided to acquire the company
• Shares of FMC Corporation (FMC) advanced 13.2% after the company agreed to buy E I Du Pont De Nemours And Co's (DD) crop protection business.
• BlackBerry Ltd’s (BBRY) shares advanced 11.5% after reporting a fiscal 2017 fourth quarter loss of $0.01 per share, which beat the Zacks Consensus Estimate of a loss of $0.04 per share
• Shares of Akari Therapeutics, Plc (AKTX) gained 58.1% after the FDA granted Fast Track designation for its treatment of paroxysmal nocturnal hemoglobinuria (PNH)
• TRC Companies, Inc.’s (TRR) shares gained 46% after private equity firm New Mountain Capital decided to acquire the compan
Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App
Zacks Investment Research